Identification of a small molecule antagonist for the Tudor domain of SMN
Liu, Y.; Iqbal, A.; Li, W.; Ni, Z.; Zhao, D. Y.; Abraham, K. J.; Tempel, W.; Guo, X.; Zhou, M.; Brown, P. J.; Qin, S.; Mekhail, K.; Greenblatt, J. F.; Min, J.
Show abstract
Survival of motor neuron (SMN), a Tudor-domain-containing protein, plays an important role in diverse biological pathways via recognition of symmetrically dimethylated arginine (Rme2s) on proteins by its Tudor domain, and deficiency of SMN leads to the motor neuron degenerative disease spinal muscular atrophy (SMA). Here we report a potent and selective antagonist with a 4-iminopyridine scaffold targeting the Tudor domain of SMN. Our structural and mutagenesis studies indicate that the sandwich stacking interactions of SMN and compound 1 play a critical role in selective binding to SMN. Various on-target engagement assays support that compound 1 recognizes SMN specifically in a cellular context. In cell studies display that the SMN antagonist prevent the interaction of SMN with R1810me2s of DNA-directed RNA polymerase II subunit POLR2A and results in transcription termination and R-loop accumulation, mimicking depletion of SMN. Thus, in addition to the antisense, RNAi and CRISPR/Cas9 techniques, the potent SMN antagonist could be used as an efficient tool in understanding the biological functions of SMN and molecular etiology in SMA.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Small Molecule Targeting IRES Domain Inhibits Enterovirus 71 Replication via an Allosteric Mechanism that Stabilizes a Ternary Complex 95%
- Potent and Selective SETDB1 Covalent Negative Allosteric Modulator Reduces Methyltransferase Activity in Cells 95%
- Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor 95%
Similar papers in this journal
- HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 94%
- Structure-based prediction of KDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates 92%
- Rapid Resistance To Bet Inhibitors Is Mediated By Fgfr1 In Glioblastoma 92%
Similar papers in this journal
- Uncovering an allosteric mode of action for a selective inhibitor of human Bloom syndrome protein 95%
- Discovery of a new class of reversible TEA-domain transcription factor inhibitors with a novel binding mode 94%
- CryoEM reveals unprecedented binding site for NaV1.7 inhibitors enabling rational design of potent hybrid inhibitors 94%
Similar papers in this journal
- Structure of human DPPA3 bound to the UHRF1 PHD finger reveals its functional and structural differences from mouse DPPA3 95%
- On-rate modulation of cadherin interactions by chemical fragments 94%
- In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.